TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.19
+0.46%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.19
From 52W high−20.94%
Volume7152.00
Market cap$25.35M
P/E (TTM)—
P/S (TTM)7.8x
Div yield—
Key dataSep 18, 2026
Open
$2.19
From 52W high
−20.94%
Volume
7152.00
Market cap
$25.35M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.2x
P/E (TTM)
—
RSI (14)
54.9
MomentumView details →
1D Return
+0.46%
YTD Return
+33.74%
SummaryUpdated Jun 1, 2026
TherapeuticsMD, Inc. (NASDAQ:TXMD) is a women's healthcare company founded in 2008 and headquartered in Boca Raton, Florida. The company went public in 2007 and specializes in developing and commercializing prescription pharmaceutical products specifically designed for women's health needs. After experiencing significant revenue growth in earlier years, the company has undergone substantial restructuring, including asset divestitures and debt reduction, and currently operates with a much smaller revenue base focused on its core women's health products.
Similar companies
Latest newsMore news →